← back to search

Zhenhua Pan

Central South University · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include RNA modifications and cancer, RNA and protein synthesis mechanisms, RNA Research and Splicing, and Cancer-related molecular mechanisms research.
h-index
18
citations
1,775
works
63
NIH funding
primary concept
email

Recent publications

66P: Long-term follow-up of limertinib (ASK120067) in patients with locally advanced or metastatic EGFR T790M NSCLC: A multicentre, single-arm, phase IIb study
Journal of Thoracic Oncology 2025cited by 1position: middledoi
Data anomaly detection for structural health monitoring using the Mixture of Bridge Experts
Structures 2024cited by 8position: middledoi
Comprehensive characterization of the in vitro and in vivo metabolites of xylocarpin H using UHPLC-Q-TOF-MS/MS
Arabian Journal of Chemistry 2024cited by 2position: lastdoi
Cost-effectiveness analysis of toripalimab plus chemotherapy for patients with advanced esophageal squamous cell carcinoma in China
Expert Review of Pharmacoeconomics & Outcomes Research 2023cited by 4position: middledoi
ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway
BMC Pharmacology and Toxicology 2022cited by 30position: middledoi
Copper(I)-promoted trifluoromethylation of indole derivates with concomitant C–C bond formation to access fused tricyclic indoles
Tetrahedron Letters 2015cited by 22position: middledoi
ChemInform Abstract: Copper(I)‐Promoted Trifluoromethylation of Indole Derivates with Concomitant C—C Bond Formation to Access Fused Tricyclic Indoles.
ChemInform 2015cited by 0position: middledoi
Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway
Biomedicine & Pharmacotherapy 2013cited by 33position: lastdoi
The inhibitory effects of m-nisoldipine on the 5-hydroxytryptamine-induced proliferation of pulmonary artery smooth muscle cells via Ca2+ antagonism and antioxidant mechanisms
European Journal of Pharmacology 2012cited by 3position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Huanlong Liu · Guilin University of Technology6 papers (2012–2023)Xueyan Chen · Qingdao University3 papers (2012–2022)Qingfeng Miao · Hebei Medical University2 papers (2012–2022)Xueyan Chen · Nankai University2 papers (2015–2015)Huiming Zhu · Tianjin University2 papers (2015–2015)Xiao‐Long Feng · Yangtze University2 papers (2015–2015)Ruixia Guo · Shanghai Ninth People's Hospital2 papers (2015–2015)Suwen Su · Hebei Medical University2 papers (2013–2022)Xin Li · Jinan University1 papers (2024–2024)Kun Li · University of Wollongong1 papers (2025–2025)Ying Liu · Shangrao Normal University1 papers (2025–2025)Linlin Zhang · Xinjiang University1 papers (2024–2024)Yan Li · South China Agricultural University1 papers (2024–2024)Guoping Chen · University of Tsukuba1 papers (2025–2025)Yun Fan · Wenzhou Medical University1 papers (2025–2025)Yongjian Zhang · Harbin Medical University1 papers (2012–2012)Yongjian Zhang · Shandong University1 papers (2013–2013)Pingping Chen · Guiyang Medical University1 papers (2013–2013)Kangsheng Gu · Jiangnan University1 papers (2025–2025)Xiaoliang Zhu · Nanfang Hospital1 papers (2024–2024)